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Abstract
Background: Candida can cause mucocutaneous and/or systemic infections in hospitalized and
immunosuppressed patients. Most individuals are colonized by Candida spp. as part of the oral flora and the
intestinal tract. We compared oral and systemic isolates for the capacity to form biofilm in an in vitro biofilm
model and pathogenicity in the Galleria mellonella infection model. The oral Candida strains were isolated from the
HIV patients and included species of C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. norvegensis, and
C. dubliniensis. The systemic strains were isolated from patients with invasive candidiasis and included species of C.
albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. lusitaniae, and C. kefyr. For each of the acquired strains, biofilm
formation was evaluated on standardized samples of silicone pads and acrylic resin. We assessed the pathogenicity
of the strains by infecting G. mellonella animals with Candida strains and observing survival.
Results: The biofilm formation and pathogenicity in Galleria was similar between oral and systemic isolates. The
quantity of biofilm formed and the virulence in G. mellonella were different for each of the species studied. On
silicone pads, C. albicans and C. dubliniensis produced more biofilm (1.12 to 6.61 mg) than the other species (0.25
to 3.66 mg). However, all Candida species produced a similar biofilm on acrylic resin, material used in dental
prostheses. C. albicans, C. dubliniensis, C. tropicalis, and C. parapsilosis were the most virulent species in G. mellonella
with 100% of mortality, followed by C. lusitaniae (87%), C. novergensis (37%), C. krusei (25%), C. glabrata (20%), and
C. kefyr (12%).
Conclusions: We found that on silicone pads as well as in the Galleria model, biofilm formation and virulence
depends on the Candida species. Importantly, for C. albicans the pathogenicity of oral Candida isolates was similar
to systemic Candida isolates, suggesting that Candida isolates have similar biofilm-forming ability and virulence
regardless of the infection site from which it was isolated.
Background
Fungi are increasingly recognized as major pathogens in
critically ill patients. Candida spp. are the fourth leading
cause of bloodstream infections in the U.S. and dissemi-
nated candidiasis is associated with a mortality in excess
of 25% [1-3]. Oropharyngeal candidiasis (OPC) is the
most frequent opportunistic infection encountered in
human immunodeficiency virus (HIV) infected indivi-
duals with 90% at some point experiencing OPC during
the course of HIV disease [4]. Among Candida species,
C. albicans is the most commonly isolated and responsi-
ble for the majority of superficial and systemic infec-
tions. However, many non-albicans species, such as C.
glabrata, C. parapsilosis and C. tropicalis have recently
emerged as important pathogens in suitably debilitated
individuals [5].
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adapt to a variety of different habitats and the conse-
quent formation of surface-attached microbial commu-
nities known as biofilms [5]. Candida biofilms can
develop on natural host surfaces or on biomaterials used
in medical devices such as silicone and in dental pros-
thesis such as acrylic resin [6,7]. The biofilm formation
in vitro entails three basic stages: (i) attachment and
colonization of yeast cells to a surface, (ii) growth and
proliferation of yeast cells to allow formation of a basal
layer of anchoring cells, and (iii) growth of pseudohy-
phae and extensive hyphae concomitant with the pro-
duction of extracellular matrix material [8,9]. Once
established, Candida biofilms serve as a persistent reser-
voir of infection and are more resistant to antifungal
agents [6].
The versatility of fungal pathogenicity mechanisms
and their development of resistance to antifungal drugs
indicate the importance of understanding the nature of
host-pathogen interactions. Researchers have developed
invertebrate model hosts in order to facilitate the study
of evolutionarily preserved elements of fungal virulence
and host immunity [10]. These invertebrate systems
such as Caenorhabditis elegans, Drosophila melanoga-
ster, Dictyostelium discoideum and Galleria mellonella
offer a number of advantages over mammalian verte-
brate models, predominantly because they allow the
study of strains without the ethical considerations asso-
ciated with mammalian studies [11-13]. Importantly,
Candida pathogenicity can be evaluated using the
greater wax moth G. mellonella as an infection model.
This model has yielded results that are comparable to
those obtained using mammalian models and there is
remarkable commonality between virulence factors
required for disease in mice and for killing of G. mello-
nella [14-17].
The pathogenesis of Candida spp. depends upon the
coordinated expression of multiple genes in a manner
that facilitates proliferation, invasion and tissue
damage in a host. Since each invaded tissue is a unique
ecological niche that changes over the course of the
disease process, the expression of genes by Candida
can vary according the infected site [18]. Costa et al.
[19] demonstrated that blood Candida isolates were
more proteolytic than oral cavity isolates while oral
cavity isolates produced more phospholipase than
blood isolates. On the other hand, Hasan et al. [20]
using colorimetric assays verified that C. albicans
strains isolated both from blood and oral mucosa pro-
duced the same quantity of biofilm. However, there are
no studies to interrogate biofilm production on medi-
cal biomaterials and pathogenicity of isolates from
localized and systemic candidiasis using an invertebrate
model.
T h eo b j e c t i v eo ft h i ss t u d yw a st oc o m p a r eb i o f i l m
production of oral and systemic Candida isolates using
an in vitro biofilm model on silicone (a material that is
used in a number of implantable devices and catheters)
and acrylic resin (a material that is used in preparation
of dental prostheses). We were also interested in deter-
mining the pathogenicity of the strains in the Galleria
mellonella infection model, considering they were iso-
l a t e df r o md i f f e r e n th o s te n vironments, either blood or
oral collection sites.
Methods
Candida isolates
A total of 33 clinical Candida strains recovered from
oral and systemic candidiasis of different patients were
used in this study. The oral Candida strains were iso-
lated from the saliva or oropharyngeal candidiasis of 17
HIV-positive patients (65% men, 35% women) at the
Emílio Ribas Institute of Infectious Diseases (São Paulo,
SP, Brazil). The mean age was 46 years (33 - 63 years)
and CD4+ lymphocyte counts ranged from 105 to 1000
cells/mm
3 with a mean count of 388 cells/mm
3. Can-
dida spp. isolated from these patients included: C. albi-
cans (n = 11), C. glabrata (n = 3), C. tropicalis (n = 2),
C. parapsilosis (n = 1), C. krusei (n = 1), C. norvegensis
(n = 1), and C. dubliniensis (n = 2). The Ethics Commit-
tee of the Emílio Ribas Institute of Infectious Diseases
approved this study (275/2009).
The systemic Candida strains were isolated from
patients with invasive candidiasis at Massachusetts Gen-
eral Hospital (Boston, MA, USA) and included species
of C. albicans (n = 5), C. glabrata (n = 2), C. tropicalis
(n = 2),C .p a r a p s i l o s i s(n = 1),C .k e f y r(n = 1), and C.
lusitaniae (n = 1) (Table 1). These isolates were col-
lected from eleven patients with a mean age of 57 years
(40-78), that were HIV negative but had other underly-
ing medical conditions. The use of Candida isolates was
approved by the Massachusetts General Hospital Institu-
tional Review Board (2008-P-001017).
The identification of Candida species was done by
growth on Hicrome Candida (Himedia, Munbai, India),
germ tube test, clamydospore formation on corn meal
agar, and API20C for sugar assimilation (BioMerieux,
Marcy Etoile, France). The identity of C. dubliniensis
was determined by a multiplex polymerase chain reac-
tion (PCR) procedure, according to the methodology
described by MähB et al. [21].
Susceptibility patterns of the isolates to fluconazole
and amphotericin B were determined by the broth
microdilution assay according to the Clinical and
Laboratory Standards Institute (CLSI) document M27-
A2 [22]. Final concentrations of fluconazole ranged
from 64 to 0.125 μg/mL and amphotericin B from 16 to
0.031 μg/mL. Antifungal activity was expressed as the
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to the drug. The resistance breakpoints were used as
described in the CLSI guidelines [22].
In vitro biofilm model
The ability of Candida isolates to form biofilm on sili-
cone and acrylic resin was evaluated as described by
Nobile & Mitchell [23] and Breger et al. [24]. In brief,
strains of Candida w e r eg r o w ni nY P Dm e d i u m( 2 %
dextrose, 2% Bacto Peptone, 1% yeast extract) overnight
at 30°C, diluted to an OD600 of 0.5 in 2 mL Spider med-
ium, and added to a well of a sterile 12-well plate con-
taining a silicone square measuring 1.5. × 1.5 cm (cut
from Cardiovascular Instrument silicone sheets) or a
chemically activated acrylic resin measuring 5 mm in
diameter and 2.5 mm in thickness (Clássico, São Paulo,
SP, Brazil) that had been pretreated overnight with
bovine serum (Sigma-Aldrich). The inoculated 12-well
plate was incubated with gentle agitation (150 rpm) for
90 min at 37°C for adhesion to occur. The standardized
samples were washed with 2 mL PBS, and incubation
was continued for 60 h at 37°C at 150 rpm in 2 mL of
fresh Spider medium.
The platform and attached biofilm were removed from
the wells, dried overnight, and weighed the following
day. The total biomass (mg) of each biofilm was calcu-
lated by subtracting the weight of the platform material
prior to biofilm growth from the weight after the drying
Table 1 Candida isolates used in this study and their susceptibility to antifungals and interactions with G. mellonella
Microorganisms Susceptibility to Antifungal
(MIC)
Galleria mellonella
Specie of
Candida
Strain of
Candida
Clinical
isolate
Fluconazole
(μg/mL)
Amph B
(μg/mL)
CFU/larva
injected
Number of killing/total Medium time to mortality (h)
C. albicans 4S Saliva 0.125 0.25 7.1 × 10
5 16/16 18
10S Saliva 0.125 0.5 5.2 × 10
5 16/16 18
24S Saliva 0.125 0.5 9.4 × 10
5 16/16 18
31S Saliva 0.125 0.5 5.0 × 10
5 16/16 24
39S Saliva Resistant 0.25 5.9 × 10
5 16/16 18
48S Saliva 0.125 0.25 6.7 × 10
5 16/16 18
60S Saliva 0.125 0.25 6.3 × 10
5 16/16 18
3 OPC 0.5 0.25 7.2 × 10
5 16/16 18
14 OPC Resistant 0.25 5.7 × 10
5 16/16 18
21 OPC Resistant 0.25 7.5 × 10
5 16/16 18
37 OPC Resistant 0.25 5.5 × 10
5 16/16 18
CAL006 Blood culture 0.125 0.5 1.9 × 10
5 16/16 24
CAL007 Peritoneal fluid 2 0.25 4.5 × 10
5 16/16 24
CAL008 Peritoneal fluid 1 0.5 7.2 × 10
5 16/16 18
CAL009 Blood culture 1 0.5 4.7 × 10
5 16/16 18
CAL010 Subdiaphragnatic 1 0.5 4.8 × 10
5 16/16 18
C. tropicalis 12 OPC 0.5 0.25 3.9 × 10
5 16/16 18
140S Saliva 0.125 0.25 4.9 × 10
5 16/16 18
CTR002 Synovial fluid Resistant 0.5 9.1 × 10
5 16/16 18
CTR003 Abdominal fluid 2 0.5 5.0 × 10
5 16/16 18
C. parapsilosis 127S Saliva 1 0.5 6.2 × 10
5 16/16 18
CPA001 Lung tissue 4 0.5 7.3 × 10
5 16/16 21
C. glabrata 12S Saliva 2 0.5 6.4 × 10
5 2/16 -
45 OPC 4 0.5 9.8 × 10
5 6/16 -
55 OPC 4 0.5 1.0 × 10
6 0/16 -
CGL002 Drainage 32 0.5 4.0 × 10
5 0/16 -
CGL003 Jackson-Pratt fluid 32 0.5 5.4 × 10
5 8/16 -
C. dubliniensis 18S Saliva 16 0.25 3.9 × 10
5 16/16 18
155S Saliva 0.5 0.25 5.1 × 10
5 16/16 18
C. lusitaniae CLU005 Blood culture 2 1 1.4 × 10
5 14/16 -
C.norvegensis 52S Saliva 32 0.5 6.3 × 10
5 6/16 -
C. krusei 58 OPC Resistant 2 8.8 × 10
5 4/16 -
C. kefyr CKE002 Blood culture 2 1 4.2 × 10
5 2/16 -
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exposed to no cells.
The average total biomass for each strain was calcu-
lated from four independent samples. Statistical signifi-
cance among the Candida species was determined by
the analyses of variance (ANOVA) and the Tukey test
using the Minitab Program. For comparison between
oral and systemic Candida isolates, the Student t test
was used. A p-value of less than 0.05 was considered
significant.
Galleria mellonella infection model
G. mellonella were infected with Candida as previously
described by Cotter et al. [25], Brennan et al. [26] and
Fuchs et al. [27]. In brief, G. mellonella caterpillars in
the final instar larval stage (Vanderhorst, Inc., St. Marys,
Ohio) were stored in the dark and used within 7 days
from the date of shipment. Sixteen randomly chosen
caterpillars (330 ± 25 mg) were infected for each Can-
dida isolate.
Candida inocula were prepared by growing 50 mL YPD
cultures overnight at 30°C. Cells were pelleted at 1,308
Xg for 10 min followed by three washes in PBS. Cell den-
sities were determined by hemacytometer count. Can-
dida inocula were confirmed by determining the colony-
forming units per milliliter (CFU/mL) on YPD.
A Hamilton syringe was used to deliver Candida
inocula at 10
5 cells/larvae in a 10 μL volume into the
hemocoel of each larva via the last left proleg. Before
injection, the area was cleaned using an alcohol swab.
After injection, larvae were incubated in plastic contain-
ers (37°C), and the number of dead G. mellonella was
scored daily. Larvae were considered dead when they
displayed no movement in response to touch. Killing
curves were plotted and statistical analysis was per-
formed by the Log-rank (Mantel-Cox) test using Graph
Pad Prism statistical software.
Results
Antifungal susceptibility of oral and systemic Candida
isolates
T h ed a t ao fCandida strains identification and suscept-
ibility to antifungal drugs (MIC) are shown in Table 1.
The range of MIC to fluconazole was 0.125 to 64 μg/
mL both for oral and systemic isolates. The resistance
to fluconazole was observed in 5 (23%) oral isolates (4
C. albicans and 1 C. krusei)a n d1( 8 % )s y s t e m i ci s o l a t e
of C. tropicalis. The MIC to amphotericin B ranged
from 0.25 to 2 μg/mL for oral isolates and from 0.25 to
1 μg/mL for systemic isolates.
Biofilm formation by oral and systemic Candida isolates
All isolates of oral and systemic candidiasis formed bio-
film on silicone pads, but the quantity of biofilm mass
was different for the species studied ranging from 2.17 to
6.61 mg. Biofilm formation was highest in C. albicans
and C. dubliniensis followed by C. tropicalis and C. nor-
vegensis. Biofilm mass formed by C. albicans differed sig-
nificantly from biofilm mass produced by C. norvegensis
(P =0 . 0 0 9 ) ,C. parapsilosis (P =0 . 0 0 3 ) ,C. glabrata (P =
0.001), C. krusei (P = 0.001), C. lusitaniae (P =0 . 0 0 1 ) ,
and C. kefyr (P = 0.001). Biofilm produced by C. dubli-
niensis was significantly different from biofilm mass pro-
duced by C. parapsilosis (P = 0.046), C. glabrata (P =
0.025), C. krusei (P = 0.013), C. lusitaniae (P =0 . 0 0 7 ) ,
and C. kefyr (P = 0.006) (Table 2 and Figure 1).
The biofilm mass adhered on acrylic resin ranged
from 0.25 to 1.50 mg depending on the Candida species
tested. C. albicans, C. dubliniensis, C. tropicalis, C.
parapsilosis, C. glabrata,a n dC. lusitaniae formed more
biofilm than C. norvegensis, C. krusei and C. kefyr. How-
ever, significant differences between the Candida species
were not observed (P = 0.062) (Table 2 and Figure 1).
The biofilm mass formed by oral and systemic isolates
of C. albicans were compared and showed similar
results both for biofilm formed on silicone pads as bio-
film formed on acrylic resin (Figure 2).
Killing of G. mellonella by oral and systemic Candida
isolates
The virulence of Candida isolates in the G. mellonella
model was dependent on the species studied. C. albi-
cans, C. dubliniensis, C. tropicalis and C. parapsilosis
were the most virulent species in G. mellonella (Table
1). Among all Candida strains studied, G. mellonella
showed mortality rates of 100% after injection with C.
albicans, C. dubliniensis, C. tropicalis,a n dC. parapsilo-
sis, 87% with C. lusitaniae, 37% with C. novergensis, 25%
with C. krusei, 20% with C. glabrata, and 12% with C.
kefyr over a 96 hour period (Figures 3 and 4). Of note is
that, all isolates of C. albicans, including strains sensitive
and resistant to fluconazole, presented the same viru-
lence in G. mellonella with a medium time to mortality
of 18 to 24 hours (Table 1).
The virulence between oral and systemic Candida iso-
lates was compared according to each species of Can-
dida. The results of survival of G. mellonella larvae
showed no statistically significant difference between
oral and systemic isolates of C. albicans (P = 0.372, Fig-
ure 3a), C. tropicalis (P = 0.914, Figure 3b), and C. para-
psilosis (P = 0.661, Figure 3c).
For C. glabrata, a statistically significant difference
was observed between the strains CGL002 and CGL003
(P = 0.003), CGL002 and 45 (P = 0.007), CGL003 and
12S (P =0 . 0 4 9 ) ,C G L 0 0 3a n d5 5( P =0 . 0 2 4 ) ,4 5a n d5 5
(P = 0.033), showing the occurrence of variation in viru-
lence between strains of C. glabrata for both the oral
isolates and the systemic isolates (Figure 3d).
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In this study we compared the pathogenicity of oral and
systemic Candida isolates. The pathogenesis of diverse
candidal diseases depends upon both generalized viru-
lence factors and those that function in specific environ-
ments dictated by immune function, tissue site and
other host factors. The data presented here demonstrate
that the pathogenicity of oral Candida isolates is similar
to systemic Candida isolates, suggesting that the patho-
genicity of Candida is not correlated with the infected
site.
The pathogenesis of both oral and systemic candidiasis
is closely dictated by properties of the yeast biofilms
[28,29]. Implanted devices,s u c ha sv e n o u sc a t h e t e r so r
dental prosthesis, are a serious risk factor for Candida
infections. They are substrates for the formation of bio-
film, which in turn serve as reservoirs of cells to conti-
nually seed an infection [8]. It has been estimated that
at least 65% of all human infectious are related to
microbial biofilms [30,31].
A variety of methods have recently been used for the
quantification of Candida biofilm on different substrata.
These include counting of colony forming units (CFU),
dry-weight assays, spectrophotometric analysis, and col-
orimetric assays, such as 2,3-bis (2-methoxy-4-nitro-5-
sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium
hydroxide (XTT) reduction assay. However, each
method carries its own advantages and limitations
[7,32,33]. In our study, we used a dry-weight assay
because this method allows the single quantification of a
Candida biofilm on a clinically relevant substrate such
as silicone and acrylic resin. Silicone is frequently used
in the manufacture of medical devices and catheters and
it is related to development of systemic candidiasis in
hospitalized patients. Acrylic resin (methyl methacrylate)
is a material widely used in preparation of dental
Table 2 Means and SDs of the biofilm mass (mg) formed on silicone pads and acrylic resin for Candida species studied
and p-value obtained for each Candida specie compared to C. albicans (Tukey test, P < 0.05)
Candida species Silicone p-value
(compared to C. albicans)
Acrylic resin p-value
(compared to C. albicans)
C. albicans 6.61 ± 0.70 - 1.12 ± 0.68 -
C. tropicalis 3.66 ± 2.22 0.062 1.41 ± 1.25 0.998
C. parapsilosis 2.87 ± 0.98 0.003 1.50 ± 0.57 0.982
C. glabrata 2.81 ± 2.09 0.001 1.15 ± 0.67 1.000
C. dubliniensis 5.85 ± 1.30 0.989 1.25 ± 0.50 1.000
C. lusitaniae 2.22 ± 0.86 0.001 1.25 ± 0.50 1.000
C. norvegensis 3.22 ± 0.66 0.001 0.25 ± 0.50 0.347
C. krusei 2.42 ± 0.84 0.001 0.25 ± 0.50 0.347
C. kefyr 2.17 ± 0.26 0.001 1.00 ± 0.00 1.000
Figure 1 Means and SDs of the biofilm mass formed on silicone pads and acrylic resin for Candida species studied.
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analysis was performed using a Student t-test.
Figure 3 Killing of G. mellonella larvae by oral (blue lines) and systemic (red lines) isolates of Candida. Comparison of killing curves by
Log-rank test: a) strains of C. albicans (P = 0.372); b) strains of C. tropicalis (P = 0.914); c) strains of C. parapsilosis (P = 0.661); d) strains of C.
glabrata (P = 0.006). Injections with PBS were used as a control group.
Junqueira et al. BMC Microbiology 2011, 11:247
http://www.biomedcentral.com/1471-2180/11/247
Page 6 of 9prosthesis and it has significance for development of
oral candidiasis.
Among all isolates tested in this study, the quantity of
biofilm mass varied according to the Candida species.
C. albicans and C. dubliniensis were the highest biofilm
producers on silicone pads, followed by C. tropicalis, C.
norvegensis, C. parapsilosis, C. glabrata, C. krusei, C.
lusitaniae,a n dC. kefyr. Most studies have shown that
the biofilm formation by clinical isolates of Candida
was species dependent and generally the highest levels
of biofilm formation were observed in C. albicans and
the lowest in C. glabrata [5,20]. Notably, unlike C. albi-
cans and other Candida species, C. glabrata is unable
to generate filamentous forms which may contribute to
the impared ability of C. glabrata to form a biofilm [5].
The observations for higher quantities of biofilm pro-
duction by C. albicans and lower biofilm production
from the non filamenting C. glabrata,g i v e nt h es a m e
standards of in vitro test conditions, remained true for
the clinical isolates from our study. Indeed, for both
strains collected orally or systemically, there was very
little in the way of quantity or quality of biofilm produc-
tion for C. glabrata. C. albicans produced the greatest
quantity of biofilm regardless of the adhesion platform
material or whether it was isolated from oral or invasive
infection sites.
Interestingly, the differences in biofilm formation
among Candida species on acrylic resin were less sig-
nificant than biofilm formed on silicone. This fact may
be attributed to the methodology used which was pre-
viously developed for biofilm formation on silicone
pads [23,24]. The process of candidal adhesion to
acylic resins is complex. Previous studies have shown
that a number of factors including the nutrient source,
the sugar used for growth (glucose or sucrose), and
the formation of pellicules from saliva or serum may
influence the adhesion and colonization of Candida
[7,29].
We also used an in vivo G. mellonella infection model
to evaluate the pathogenicity of oral and systemic Can-
dida isolates. There are some benefits to using G. mello-
nella larvae as a model host to study Candida compare
to other invertebrate models. For example, the larvae
can be maintained at a temperature range from 25°C to
37°C, thus facilitating a number of temperature condi-
tions under which fungi exist in either natural environ-
mental niches or mammalian hosts. High temperatures
can be prohibitive for the growth of C. elegans or Droso-
phila infection models. Our study used 37°C to mimic
mammalian infection systems. G. mellonella also has the
benefit of facile inoculation methods either by injection
or topical application, where injection inoculation pro-
vides a means to deliver a precise amount of fungal cells
[12,27,34]. By contrast, other systems, such as C. ele-
gans, require infection through ingesting the pathogen.
S i n c ew ei n c l u d e db o t halbicans and non-albicans
strains in our study we thought it prudent to use a
model that ensured equal pathogen delivery rather than
a model that would have an aversion to consuming
some of the infecting agents.
As with the biofilm assays, the virulence levels of Can-
dida isolates in G. mellonella were dependent on the
species studied. Surprisingly, within the same species,
oral isolates were as virulent as isolates from candide-
mia, the most common severe Candida infection. Pre-
viously, Cotter et al. [25] reported that it is possible to
distinguish between different levels of pathogenicity
within the genus Candida using G. mellonella larvae.
We observed that G. mellonella showed mortality rates
of 100% after injection with 10
5 cells of C. albicans, C.
dubliniensis, C. tropicalis,a n dC. parapsilosis,8 7 %w i t h
C. lusitaniae,3 7 %w i t hC. novergensis,2 5 %w i t hC.
Figure 4 Killing of G. mellonella larvae by isolates of C. dubliniensis, C. lusitaniae, C. norvegensis, C. krusei, and C. kefyr. Injections with
PBS were used as a control group.
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a 96 hour period of incubation at 37°C. Cotter et al.
[25] verified mortality rates of 90% for C. albicans, 70%
for C. tropicalis, 45% for C. parapsilosis, 20% for C. kru-
sei,a n d0 %f o rC. glabrata over a 72 hour period of
incubation at 30°C after the injection with 10
6 cells of
each Candida species. Probably, the virulence of the
Candida strains in G. mellonella tested in this study
were higher than the virulence of Candida strains
observed by Cotter et al. [25] because of the difference
of incubation temperature used. The temperature varia-
tions can affect gene expression and consequently the
level of virulence of Candida strains [35].
Of note is that this is the first study to inoculate spe-
cies of C. lusitaniae, C. norvegensis and C. dubliniensis
in the G. mellonella model. Single isolates for C. lusta-
niae and C. norvegensis and two isolates of C. dublinien-
sis were included in our study. C. lusitaniae is
considered an emerging non-albicans Candida species
and isolates show resistance to amphotericin B. C. nor-
vegensis appears to be a rare cause of human infection
and the most of the isolates are resistant to fluconazole
[36,37]. There are limited data on the comparative viru-
lence of C. lusitaniae and C. norvegensis in relation to
C. albicans. In this study, C. lusitaniae and C. norvegen-
sis were less virulent in G. mellonella than C. albicans.
Finally, in our study, C. dubliniensis isolates showed
that the ability of biofilm formation and killing G. mello-
nella was similar to C. albicans. C. dubliniensis has been
implicated in oropharyngeal candidiasis in HIV-infected
patients, althought it has also been isolated from other
anatomical sites, including lungs, vagina, blood, and
feces [38,39]. Despite the significant phenotypic and
genotypic similarities shared between C. albicans and C.
dubliniensis, the comparative virulence of the two spe-
cies is clearly a very complex topic [40,41]. Borecká-
Melkusová [42] verified that the biofilm formation in C.
albicans was significantly lower than in C. dubliniensis,
a n dK o g a - I t oe ta l .[ 4 3 ]o b s e r v e dt h a tt h es u r v i v a lr a t e
and dissemination capacity of C. dubliniensis in mice
were lower than C. albicans.
Conclusion
In summary, in Candida spp., the ability of biofilm for-
mation and virulence in the G. mellonella model were
dependent on the species studied. For C. albicans the
pathogenicity of oral isolates was similar to that of sys-
temic isolates, suggesting that oral Candida infections
should be taken seriously as they have the potential to
be as equally morbid if they become systemic infections.
Of note is that the penetration by C. albicans filaments
is critical during the course of the infection in the Gal-
leria tissue [17]. However, this model does not focus on
invasion. Further studies are needed in order to study
the ability of oral isolates to colonize and penetrate
tissues.
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